Does glucose-6-phosphate dehydrogenase deficiency worsen the clinical features of sickle cell disease? A multi-hospital-based cross-sectional study

Background The impact of glucose-6-phosphate dehydrogenase deficiency(G-6-PD) on the clinical course of sickle cell disease(SCD) is still controversial. The objectives of this study were to determine the prevalence of G-6-PD deficiency in patients with SCD and its effect on their clinical course.Met...

Full description

Bibliographic Details

Published in:	Hematology
Main Authors:	Paul Kambale-Kombi, Roland Marini Djang’eing’a, Jean-Pierre Alworong’a Opara, Jean-Marc Minon, Camille Atoba Bokele, Vincent Bours, Marie-Agnès Azerad, Serge Tonen-Wolyec, Charles Kayembe Tshilumba, Salomon Batina-Agasa
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2022-12-01
Subjects:	Sickle cell disease G-6-PD deficiency prevalence clinical features Democratic Republic of the Congo comorbidity
Online Access:	https://www.tandfonline.com/doi/10.1080/16078454.2022.2074715